Real-world biologics response and super-response in the International Severe Asthma Registry cohort
(LUMINANT)

John Busby, David Price, Riyad Al-Lehebi, Sinthia Bosnic-Anticevich, Job FM van Boven, Benjamin Emmanuel, Mark FitzGerald, Mina Gaga, Susanne Hansen, Mark Hew, Takashi Iwanaga, Désirée Larenas-Linnemann, Bassam Mahboub, Patrick Mitchell, Daniela Morrone, Jonathan Pham, Celeste Porsbjerg, Nicolas Roche, Eileen Wang, Neva Eleangovan, Liam Heaney

Exploring definitions and predictors of response to biologics for severe asthma (FULL BEAM I Response)

John Busby, David Price, Riyad Al-Lehebi, Sinthia Bosnic-Anticevich, Job FM van Boven, Benjamin Emmanuel, Mark FitzGerald, Mina Gaga, Susanne Hansen, Mark Hew, Takashi Iwanaga, Désirée Larenas-Linnemann, Bassam Mahboub, Patrick Mitchell, Daniela Morrone, Jonathan Pham, Celeste Porsbjerg, Nicolas Roche, Eileen Wang, Neva Eleangovan, Liam Heaney

Exploring different definitions and predictors of severe asthma remission after biologic treatment (FULL BEAM II Response)

John Busby, David Price, Riyad Al-Lehebi, Sinthia Bosnic-Anticevich, Job FM van Boven, Benjamin Emmanuel, Mark FitzGerald, Mina Gaga, Susanne Hansen, Mark Hew, Takashi Iwanaga, Désirée Larenas-Linnemann, Bassam Mahboub, Patrick Mitchell, Daniela Morrone, Jonathan Pham, Celeste Porsbjerg, Nicolas Roche, Eileen Wang, Neva Eleangovan, Liam Heaney

Association between pre-biologic T2-biomaker combinations and response to biologics in patients with severe asthma (IGNITE)

John Busby, David Price, Riyad Al-Lehebi, Sinthia Bosnic-Anticevich, Job FM van Boven, Benjamin Emmanuel, Mark FitzGerald, Mina Gaga, Susanne Hansen, Mark Hew, Takashi Iwanaga, Désirée Larenas-Linnemann, Bassam Mahboub, Patrick Mitchell, Daniela Morrone, Jonathan Pham, Celeste Porsbjerg, Nicolas Roche, Eileen Wang, Neva Eleangovan, Liam Heaney

International variation in severe exacerbation rates in patients with severe asthma

John Busby, David Price, Riyad Al-Lehebi, Sinthia Bosnic-Anticevich, Job FM van Boven, Benjamin Emmanuel, Mark FitzGerald, Mina Gaga, Susanne Hansen, Mark Hew, Takashi Iwanaga, Désirée Larenas-Linnemann, Bassam Mahboub, Patrick Mitchell, Daniela Morrone, Jonathan Pham, Celeste Porsbjerg, Nicolas Roche, Eileen Wang, Neva Eleangovan, Liam Heaney

Reply to "Exploring the long-term effects of biologic initiation in severe asthma: Insights from the International Severe Asthma Registry"

John Busby, David Price, Riyad Al-Lehebi, Sinthia Bosnic-Anticevich, Job FM van Boven, Benjamin Emmanuel, Mark FitzGerald, Mina Gaga, Susanne Hansen, Mark Hew, Takashi Iwanaga, Désirée Larenas-Linnemann, Bassam Mahboub, Patrick Mitchell, Daniela Morrone, Jonathan Pham, Celeste Porsbjerg, Nicolas Roche, Eileen Wang, Neva Eleangovan, Liam Heaney

Association between T2-related co-morbidities and effectiveness of biologics in severe asthma (PRISM II)

John Busby, David Price, Riyad Al-Lehebi, Sinthia Bosnic-Anticevich, Job FM van Boven, Benjamin Emmanuel, Mark FitzGerald, Mina Gaga, Susanne Hansen, Mark Hew, Takashi Iwanaga, Désirée Larenas-Linnemann, Bassam Mahboub, Patrick Mitchell, Daniela Morrone, Jonathan Pham, Celeste Porsbjerg, Nicolas Roche, Eileen Wang, Neva Eleangovan, Liam Heaney

Impact of pre-biologic impairment on meeting domain-specific biologic responder definitions in patients with severe asthma (BEAM)

John Busby, David Price, Riyad Al-Lehebi, Sinthia Bosnic-Anticevich, Job FM van Boven, Benjamin Emmanuel, Mark FitzGerald, Mina Gaga, Susanne Hansen, Mark Hew, Takashi Iwanaga, Désirée Larenas-Linnemann, Bassam Mahboub, Patrick Mitchell, Daniela Morrone, Jonathan Pham, Celeste Porsbjerg, Nicolas Roche, Eileen Wang, Neva Eleangovan, Liam Heaney

Adult severe asthma registries: a global and growing inventory (INVENTORY)

John Busby, David Price, Riyad Al-Lehebi, Sinthia Bosnic-Anticevich, Job FM van Boven, Benjamin Emmanuel, Mark FitzGerald, Mina Gaga, Susanne Hansen, Mark Hew, Takashi Iwanaga, Désirée Larenas-Linnemann, Bassam Mahboub, Patrick Mitchell, Daniela Morrone, Jonathan Pham, Celeste Porsbjerg, Nicolas Roche, Eileen Wang, Neva Eleangovan, Liam Heaney

Analysis of comorbidities and multimorbidity in adult patients in the International Severe Asthma Registry (PRISM I)

John Busby, David Price, Riyad Al-Lehebi, Sinthia Bosnic-Anticevich, Job FM van Boven, Benjamin Emmanuel, Mark FitzGerald, Mina Gaga, Susanne Hansen, Mark Hew, Takashi Iwanaga, Désirée Larenas-Linnemann, Bassam Mahboub, Patrick Mitchell, Daniela Morrone, Jonathan Pham, Celeste Porsbjerg, Nicolas Roche, Eileen Wang, Neva Eleangovan, Liam Heaney

Impact of Initiating Biologics In Patients with severe asthma and on Long-Term OCS Or Frequent Rescue Steroids (GLITTER Phase II)

John Busby, David Price, Riyad Al-Lehebi, Sinthia Bosnic-Anticevich, Job FM van Boven, Benjamin Emmanuel, Mark FitzGerald, Mina Gaga, Susanne Hansen, Mark Hew, Takashi Iwanaga, Désirée Larenas-Linnemann, Bassam Mahboub, Patrick Mitchell, Daniela Morrone, Jonathan Pham, Celeste Porsbjerg, Nicolas Roche, Eileen Wang, Neva Eleangovan, Liam Heaney

The comparative effectiveness of Anti-IL5 and Anti-IgE biologic classes in severe asthma patients eligible for both (FIRE)

John Busby, David Price, Riyad Al-Lehebi, Sinthia Bosnic-Anticevich, Job FM van Boven, Benjamin Emmanuel, Mark FitzGerald, Mina Gaga, Susanne Hansen, Mark Hew, Takashi Iwanaga, Désirée Larenas-Linnemann, Bassam Mahboub, Patrick Mitchell, Daniela Morrone, Jonathan Pham, Celeste Porsbjerg, Nicolas Roche, Eileen Wang, Neva Eleangovan, Liam Heaney